Additional Guidance Regarding the Vigilance System as outlined in MEDDEV 2.12-1 rev. 8
EU – Additional Guidance Regarding the Vigilance System as outlined in MEDDEV 2.12-1 rev. 8
Published in Guidance, Guidance MEDDEV, Medical Device Vigilance and Medical Devices Directive - MDD
More from GuidanceMore posts in Guidance »
- EU – MDCG 2020-5 Clinical Evaluation – Equivalence. A guide for manufacturers and notified bodies
- EU – Guidance on temporary extraordinary measures related to medical device Notified Body audits during COVID-19 quarantine orders and travel restrictions
- US – FDA Issues Immediately in Effect Guidance on Ventilators During COVID-19
- UU – Final guidance – Premarket Notification (510(k)) Submissions for Electrosurgical Devices for General Surgery
- US Final Guidance – Bone Anchors – Premarket Notification (510(k)) Submissions
More from Guidance MEDDEVMore posts in Guidance MEDDEV »
More from Medical Device VigilanceMore posts in Medical Device Vigilance »
More from Medical Devices Directive - MDDMore posts in Medical Devices Directive - MDD »
- EU – Commission Implementing Regulation (EU) 2020/666 of 18 May 2020 amending Implementing Regulation (EU) No 920/2013 as regards the renewal of designations and the surveillance and monitoring of notified bodies
- EU – Manufacturer incident report 2020
- EU – MDCG 2020-6 Regulation (EU) 2017/745: Clinical evidence needed for medical devices previously CE marked under Directives 93/42/EEC or 90/385/EEC. A guide for manufacturers and notified bodies
- EU – REGULATION (EU) 2020/561 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 23 April 2020 amending Regulation (EU) 2017/745 on medical devices, as regards the dates of application of certain of its provisions
- EU – Guidance on temporary extraordinary measures related to medical device Notified Body audits during COVID-19 quarantine orders and travel restrictions
Be First to Comment